Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Scott D Lane

3 papers in the library · 52 citations · publishing 2007-2024

Papers

Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making

The American Journal of Drug and Alcohol Abuse January 1, 2007 F. Gerard Moeller, Joel L. Steinberg, Scott D Lane et al. 39 citations

MDMA users showed reduced longitudinal diffusivity in the rostral body of the corpus callosum, indicating possible microstructural changes, while no differences were found in other diffusivity measures. MDMA users also reported higher impulsivity on the Barratt Impulsiveness Scale and made more disadvantageous choices on the Iowa Gambling Task. A positive correlation emerged between longitudinal diffusivity in the rostral corpus callosum and advantageous decision-making, suggesting a link between white matter integrity and cognitive performance. Further research is needed to understand the causes of these associations.

A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder.

The Journal of Clinical Psychiatry April 24, 2024 Gregory H Jones, Courtney M Vecera, Ana C Ruiz et al. 13 citations

A single dose of intranasal ketamine (50 mg) produced rapid antidepressant effects compared to placebo in unmedicated inpatients with major depression and current suicidal ideation, but did not significantly reduce suicidal thoughts. Patients with comorbid alcohol use disorder showed a statistical trend toward greater improvement in suicidality, though the primary outcome was not met. The treatment was well tolerated. The antidepressant benefit was largely unaffected by the presence of alcohol use disorder or the type of mood disorder (unipolar or bipolar). Among those receiving ketamine, improvement in depression correlated with reduced suicidal ideation only in patients without alcohol use disorder.

The effect of intranasal (R,S)-ketamine on symptoms of fatigue in severe major depressive disorder or bipolar depression with and without comorbid alcohol use disorder: Results from a randomized, double-blind, placebo-controlled trial.

Journal of Affective Disorders December 15, 2024 Rodrigo Machado‐Vieira, Gregory H Jones, Alan C. Courtes et al.

Fatigue, a multidimensional condition that often overlaps with depression, responds only modestly to standard antidepressants and mood stabilizers but has shown positive response to intravenous ketamine, which is limited by cost and access. This study evaluated a single 50 mg dose of intranasal ketamine in 28 individuals with major depressive disorder or bipolar depression, about 60% of whom also had alcohol use disorder. The group by time interaction for the NIH-Brief Fatigue Inventory score was significant, favoring intranasal ketamine over placebo at 4, 24, and 48 hours post-treatment. Intranasal ketamine was well-tolerated with minimal adverse effects. The findings suggest intranasal ketamine induces rapid anti-fatigue effects and may serve as an alternative rapid-acting option for fatigue across different medical conditions.